CONMED CORP (CNMD) Fundamental Analysis & Valuation

NYSE:CNMD • US2074101013

Current stock price

36.79 USD
-1.08 (-2.85%)
At close:
36.79 USD
0 (0%)
After Hours:

This CNMD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. CNMD Profitability Analysis

1.1 Basic Checks

  • In the past year CNMD was profitable.
  • CNMD had a positive operating cash flow in the past year.
  • CNMD had positive earnings in 4 of the past 5 years.
  • CNMD had a positive operating cash flow in each of the past 5 years.
CNMD Yearly Net Income VS EBIT VS OCF VS FCFCNMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M 200M

1.2 Ratios

  • The Return On Assets of CNMD (2.02%) is better than 73.26% of its industry peers.
  • CNMD has a better Return On Equity (4.55%) than 75.94% of its industry peers.
  • The Return On Invested Capital of CNMD (4.23%) is better than 73.26% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CNMD is below the industry average of 9.12%.
Industry RankSector Rank
ROA 2.02%
ROE 4.55%
ROIC 4.23%
ROA(3y)3.52%
ROA(5y)2.12%
ROE(3y)8.68%
ROE(5y)4.64%
ROIC(3y)5.32%
ROIC(5y)4.74%
CNMD Yearly ROA, ROE, ROICCNMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 -10

1.3 Margins

  • CNMD has a better Profit Margin (3.42%) than 74.33% of its industry peers.
  • CNMD's Profit Margin has improved in the last couple of years.
  • CNMD has a Operating Margin of 8.39%. This is in the better half of the industry: CNMD outperforms 76.47% of its industry peers.
  • CNMD's Operating Margin has improved in the last couple of years.
  • CNMD has a Gross Margin (54.59%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of CNMD has remained more or less at the same level.
Industry RankSector Rank
OM 8.39%
PM (TTM) 3.42%
GM 54.59%
OM growth 3Y4.64%
OM growth 5Y1.5%
PM growth 3YN/A
PM growth 5Y25.45%
GM growth 3Y-0.47%
GM growth 5Y-0.15%
CNMD Yearly Profit, Operating, Gross MarginsCNMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. CNMD Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CNMD is destroying value.
  • Compared to 1 year ago, CNMD has more shares outstanding
  • CNMD has more shares outstanding than it did 5 years ago.
  • CNMD has a better debt/assets ratio than last year.
CNMD Yearly Shares OutstandingCNMD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
CNMD Yearly Total Debt VS Total AssetsCNMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • Based on the Altman-Z score of 1.81, we must say that CNMD is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.81, CNMD is in line with its industry, outperforming 55.62% of the companies in the same industry.
  • The Debt to FCF ratio of CNMD is 5.53, which is a neutral value as it means it would take CNMD, 5.53 years of fcf income to pay off all of its debts.
  • CNMD has a Debt to FCF ratio of 5.53. This is in the better half of the industry: CNMD outperforms 74.87% of its industry peers.
  • CNMD has a Debt/Equity ratio of 0.81. This is a neutral value indicating CNMD is somewhat dependend on debt financing.
  • CNMD has a Debt to Equity ratio of 0.81. This is in the lower half of the industry: CNMD underperforms 74.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 5.53
Altman-Z 1.81
ROIC/WACC0.71
WACC5.98%
CNMD Yearly LT Debt VS Equity VS FCFCNMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

  • CNMD has a Current Ratio of 2.14. This indicates that CNMD is financially healthy and has no problem in meeting its short term obligations.
  • With a Current ratio value of 2.14, CNMD perfoms like the industry average, outperforming 40.64% of the companies in the same industry.
  • CNMD has a Quick Ratio of 1.01. This is a normal value and indicates that CNMD is financially healthy and should not expect problems in meeting its short term obligations.
  • CNMD has a worse Quick ratio (1.01) than 82.89% of its industry peers.
Industry RankSector Rank
Current Ratio 2.14
Quick Ratio 1.01
CNMD Yearly Current Assets VS Current LiabilitesCNMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CNMD Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 10.82% over the past year.
  • The Earnings Per Share has been growing by 16.37% on average over the past years. This is quite good.
  • CNMD shows a small growth in Revenue. In the last year, the Revenue has grown by 5.18%.
  • The Revenue has been growing by 9.77% on average over the past years. This is quite good.
EPS 1Y (TTM)10.82%
EPS 3Y20.27%
EPS 5Y16.37%
EPS Q2Q%6.72%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y9.55%
Revenue growth 5Y9.77%
Sales Q2Q%7.88%

3.2 Future

  • CNMD is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.09% yearly.
  • CNMD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.55% yearly.
EPS Next Y-3.63%
EPS Next 2Y4.41%
EPS Next 3Y7.09%
EPS Next 5YN/A
Revenue Next Year-0.72%
Revenue Next 2Y2.34%
Revenue Next 3Y3.55%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CNMD Yearly Revenue VS EstimatesCNMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
CNMD Yearly EPS VS EstimatesCNMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

8

4. CNMD Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 7.98 indicates a rather cheap valuation of CNMD.
  • Based on the Price/Earnings ratio, CNMD is valued cheaper than 94.12% of the companies in the same industry.
  • CNMD is valuated cheaply when we compare the Price/Earnings ratio to 26.91, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 8.28, the valuation of CNMD can be described as reasonable.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CNMD indicates a rather cheap valuation: CNMD is cheaper than 96.26% of the companies listed in the same industry.
  • CNMD's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.99.
Industry RankSector Rank
PE 7.98
Fwd PE 8.28
CNMD Price Earnings VS Forward Price EarningsCNMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • CNMD's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CNMD is cheaper than 90.91% of the companies in the same industry.
  • 98.40% of the companies in the same industry are more expensive than CNMD, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.35
EV/EBITDA 10.04
CNMD Per share dataCNMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

  • The decent profitability rating of CNMD may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.49
EPS Next 2Y4.41%
EPS Next 3Y7.09%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. CNMD Dividend Analysis

5.1 Amount

  • CNMD has a Yearly Dividend Yield of 2.13%.
  • Compared to an average industry Dividend Yield of 0.25, CNMD pays a better dividend. On top of this CNMD pays more dividend than 95.72% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, CNMD has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.13%

5.2 History

  • The dividend of CNMD has a limited annual growth rate of 0.10%.
  • CNMD has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)0.1%
Div Incr Years0
Div Non Decr Years0
CNMD Yearly Dividends per shareCNMD Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

  • 52.59% of the earnings are spent on dividend by CNMD. This is a bit on the high side, but may be sustainable.
  • The dividend of CNMD is growing, but earnings are growing more, so the dividend growth is sustainable.
DP52.59%
EPS Next 2Y4.41%
EPS Next 3Y7.09%
CNMD Yearly Income VS Free CF VS DividendCNMD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M
CNMD Dividend Payout.CNMD Dividend Payout, showing the Payout Ratio.CNMD Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CNMD Fundamentals: All Metrics, Ratios and Statistics

CONMED CORP

NYSE:CNMD (4/28/2026, 8:22:06 PM)

After market: 36.79 0 (0%)

36.79

-1.08 (-2.85%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Industry Strength10.56
Industry Growth62.11
Earnings (Last)01-28
Earnings (Next)04-29
Inst Owners112.85%
Inst Owner Change-1.86%
Ins Owners0.28%
Ins Owner Change1.42%
Market Cap1.11B
Revenue(TTM)1.37B
Net Income(TTM)47.05M
Analysts50.91
Price Target45.08 (22.53%)
Short Float %7.7%
Short Ratio5.36
Dividend
Industry RankSector Rank
Dividend Yield 2.13%
Yearly Dividend0.8
Dividend Growth(5Y)0.1%
DP52.59%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.3%
Min EPS beat(2)0.66%
Max EPS beat(2)5.94%
EPS beat(4)4
Avg EPS beat(4)5.44%
Min EPS beat(4)0.37%
Max EPS beat(4)14.78%
EPS beat(8)8
Avg EPS beat(8)5.62%
EPS beat(12)11
Avg EPS beat(12)4.63%
EPS beat(16)13
Avg EPS beat(16)0.77%
Revenue beat(2)0
Avg Revenue beat(2)-0.64%
Min Revenue beat(2)-1.03%
Max Revenue beat(2)-0.25%
Revenue beat(4)1
Avg Revenue beat(4)-0.38%
Min Revenue beat(4)-1.03%
Max Revenue beat(4)0.51%
Revenue beat(8)1
Avg Revenue beat(8)-0.84%
Revenue beat(12)3
Avg Revenue beat(12)-0.05%
Revenue beat(16)4
Avg Revenue beat(16)-1.46%
PT rev (1m)-6.75%
PT rev (3m)-8.68%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-11.97%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.99%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.63%
Valuation
Industry RankSector Rank
PE 7.98
Fwd PE 8.28
P/S 0.81
P/FCF 7.35
P/OCF 6.5
P/B 1.07
P/tB N/A
EV/EBITDA 10.04
EPS(TTM)4.61
EY12.53%
EPS(NY)4.44
Fwd EY12.08%
FCF(TTM)5.01
FCFY13.61%
OCF(TTM)5.66
OCFY15.39%
SpS45.61
BVpS34.28
TBVpS-11.81
PEG (NY)N/A
PEG (5Y)0.49
Graham Number59.6267 (62.07%)
Profitability
Industry RankSector Rank
ROA 2.02%
ROE 4.55%
ROCE 5.74%
ROIC 4.23%
ROICexc 4.31%
ROICexgc 14.63%
OM 8.39%
PM (TTM) 3.42%
GM 54.59%
FCFM 10.98%
ROA(3y)3.52%
ROA(5y)2.12%
ROE(3y)8.68%
ROE(5y)4.64%
ROIC(3y)5.32%
ROIC(5y)4.74%
ROICexc(3y)5.4%
ROICexc(5y)4.81%
ROICexgc(3y)19.18%
ROICexgc(5y)17.21%
ROCE(3y)7.22%
ROCE(5y)6.44%
ROICexgc growth 3Y7.2%
ROICexgc growth 5Y4.14%
ROICexc growth 3Y14.69%
ROICexc growth 5Y5.99%
OM growth 3Y4.64%
OM growth 5Y1.5%
PM growth 3YN/A
PM growth 5Y25.45%
GM growth 3Y-0.47%
GM growth 5Y-0.15%
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 5.53
Debt/EBITDA 4.4
Cap/Depr 26.66%
Cap/Sales 1.44%
Interest Coverage 4.54
Cash Conversion 90.02%
Profit Quality 320.65%
Current Ratio 2.14
Quick Ratio 1.01
Altman-Z 1.81
F-Score5
WACC5.98%
ROIC/WACC0.71
Cap/Depr(3y)23.78%
Cap/Depr(5y)24.75%
Cap/Sales(3y)1.32%
Cap/Sales(5y)1.51%
Profit Quality(3y)200.6%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.82%
EPS 3Y20.27%
EPS 5Y16.37%
EPS Q2Q%6.72%
EPS Next Y-3.63%
EPS Next 2Y4.41%
EPS Next 3Y7.09%
EPS Next 5YN/A
Revenue 1Y (TTM)5.18%
Revenue growth 3Y9.55%
Revenue growth 5Y9.77%
Sales Q2Q%7.88%
Revenue Next Year-0.72%
Revenue Next 2Y2.34%
Revenue Next 3Y3.55%
Revenue Next 5YN/A
EBIT growth 1Y-44.98%
EBIT growth 3Y14.64%
EBIT growth 5Y11.42%
EBIT Next Year26.75%
EBIT Next 3Y14.3%
EBIT Next 5YN/A
FCF growth 1Y-1.95%
FCF growth 3Y135.18%
FCF growth 5Y23.98%
OCF growth 1Y2.23%
OCF growth 3Y72.25%
OCF growth 5Y21.49%

CONMED CORP / CNMD Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CONMED CORP (CNMD) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CNMD.


Can you provide the valuation status for CONMED CORP?

ChartMill assigns a valuation rating of 8 / 10 to CONMED CORP (CNMD). This can be considered as Undervalued.


Can you provide the profitability details for CONMED CORP?

CONMED CORP (CNMD) has a profitability rating of 6 / 10.


How financially healthy is CONMED CORP?

The financial health rating of CONMED CORP (CNMD) is 4 / 10.


How sustainable is the dividend of CONMED CORP (CNMD) stock?

The dividend rating of CONMED CORP (CNMD) is 5 / 10 and the dividend payout ratio is 52.59%.